295 related articles for article (PubMed ID: 11180734)
1. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
2. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women.
Hindorff LA; Psaty BM; Carlson CS; Heckbert SR; Lumley T; Smith NL; Lemaitre RN; Rieder MJ; Nickerson DA; Reiner AP
Am J Epidemiol; 2006 Apr; 163(7):600-7. PubMed ID: 16467413
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.
Reiner AP; Heckbert SR; Vos HL; Ariëns RA; Lemaitre RN; Smith NL; Lumley T; Rea TD; Hindorff LA; Schellenbaum GD; Rosendaal FR; Siscovick DS; Psaty BM
Blood; 2003 Jul; 102(1):25-30. PubMed ID: 12456499
[TBL] [Abstract][Full Text] [Related]
5. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.
Psaty BM; Smith NL; Heckbert SR; Vos HL; Lemaitre RN; Reiner AP; Siscovick DS; Bis J; Lumley T; Longstreth WT; Rosendaal FR
JAMA; 2002 Apr; 287(13):1680-9. PubMed ID: 11926892
[TBL] [Abstract][Full Text] [Related]
6. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.
Doggen CJ; Cats VM; Bertina RM; Rosendaal FR
Circulation; 1998 Mar; 97(11):1037-41. PubMed ID: 9531249
[TBL] [Abstract][Full Text] [Related]
7. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
8. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy.
Botto N; Maffei S; Manfredi S; Colombo MG; Mazzone AM; Andreassi MG
Climacteric; 2011 Feb; 14(1):25-30. PubMed ID: 21073356
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.
Herrington DM; Vittinghoff E; Howard TD; Major DA; Owen J; Reboussin DM; Bowden D; Bittner V; Simon JA; Grady D; Hulley SB
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1012-7. PubMed ID: 12067913
[TBL] [Abstract][Full Text] [Related]
11. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
12. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal estrogens and risk of myocardial infarction in diabetic women.
Kaplan RC; Heckbert SR; Weiss NS; Wahl PW; Smith NL; Newton KM; Psaty BM
Diabetes Care; 1998 Jul; 21(7):1117-21. PubMed ID: 9653605
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
[TBL] [Abstract][Full Text] [Related]
15. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
18. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.
Rosendaal FR; Vessey M; Rumley A; Daly E; Woodward M; Helmerhorst FM; Lowe GD
Br J Haematol; 2002 Mar; 116(4):851-4. PubMed ID: 11886391
[TBL] [Abstract][Full Text] [Related]
19. Estrogen plus progestin and risk of venous thrombosis.
Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
[TBL] [Abstract][Full Text] [Related]
20. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
